scispace - formally typeset
T

Taiwo Ayodele Oriola

Researcher at Ulster University

Publications -  17
Citations -  104

Taiwo Ayodele Oriola is an academic researcher from Ulster University. The author has contributed to research in topics: Legal research & Empirical legal studies. The author has an hindex of 5, co-authored 17 publications receiving 101 citations. Previous affiliations of Taiwo Ayodele Oriola include National University of Singapore.

Papers
More filters
Journal ArticleDOI

Advance Fee Fraud on the Internet: Nigeria's Regulatory Response

TL;DR: How the international community might help to tackle Internet scam crime is highlighted and a case for greater systemic transparency, legal enforcement readiness, intensification of public enlightenment campaigns and technological approaches to combat the menace of advance fee fraud on the Internet is made.
Journal ArticleDOI

Ethical and Legal Analyses of Policy Prohibiting Tobacco Smoking in Enclosed Public Spaces

TL;DR: No other risky, self-indulgent addictive behaviors such as cocaine abuse directly endanger bystanders as much as cigarette smoking or tobacco use endangers nonsmokers through secondhand tobacco smoke or inhaled environmental tobacco smoke (ETS).
Posted Content

Consumer Dilemmas: The Right to Know, Safety, Ethics and Policy of Genetically Modified Food

TL;DR: Examining the disparate scientific views on GM food safety, the place of consumer's choice, legal, and ethical issues in GM food governance in the context of Singapore, which relies entirely on food imports is examined.
Journal Article

Strong medicine: patents, market, and policy challenges for managing neglected diseases and affordable prescription drugs

TL;DR: Using empirical data and relevant literature, the paper critically reviews the cumulative effects of the legal and socio-economic externalities that shape the current global pharmaceutical production trajectory and canvasses for the supplementation of the current patents and markets driven monocultural prescription drug economics with a normative, non-market, internationally mediated drug production paradigm that is cognisant of the overriding public health needs.